title: A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both?
abstract: We herein report a 12-year-old boy with amoxicillin-induced, recurrent, site-specific, symmetrical, sharply demarcated reddish plaques on the buttocks and the major flexural and intertriginous areas. The lesions resolved with topical corticosteroids, leaving hyperpigmentation. Histopathology showed nonspecific features of inflammation and dermal melanophages. Amoxicillin was the probable inducer based on oral provocation test with Amoksina(®)  tablet, however patch testing with amoxicillin on previously affected and unaffected skin remained negative. The diagnosis was challenging because of the overlapping features of symmetrical drug-related intertriginous and flexural exanthema and fixed drug eruption. This one represents a unique and challenging one with overlapping clinical features of symmetrical drug-related intertriginous and flexural exanthem (SDRIFE) and fixed drug eruption (FDE). We discuss the possible immunopathogenetic mechanisms leading to the simultaneous occurrence of different phenotypes of drug eruption in the same patient.
authors.affiliation: Department of Dermatology and Venereology, İstanbul Medical Faculty, İstanbul University, İstanbul, Turkey.
authors.forename: Esen
authors.initials: E
authors.lastname: Özkaya
authors.affiliation: Department of Dermatology and Venereology, İstanbul Medical Faculty, İstanbul University, İstanbul, Turkey.
authors.forename: Goncagül
authors.initials: G
authors.lastname: Babuna
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000658:Amoxicillin / Q000009:adverse effects*; D002081:Buttocks; D002648:Child; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy; D005076:Exanthema / Q000175:diagnosis*; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology; D008297:Male; D010328:Patch Tests; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000658:Amoxicillin
references.citation: Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.
references.citation: Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004;51:297-310.
references.citation: Häusermann P, Bircher AJ. SDRIFE - another acronym for a distinct cutaneous drug exanthema: do we really need it? Dermatology 2007;214:1-2.
references.citation: Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Dermatitis 1984;10:97-100.
references.citation: Ozkaya E. Current understanding of Baboon syndrome. Expert Rev Dermatol 2009;4:163-175.
references.citation: Pichler WJ, Beeler A, Keller M et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 2006;55:17-25.
references.citation: Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol 2009;34:355-357.
references.citation: Ozkaya E. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008;6:181-188.
references.citation: Shelley WB, Shelley ED. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987;17:403-407.
references.citation: Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007;37:989-999.
references.citation: Yawalkar N, Pichler WJ. [Mechanisms of cutaneous drug reactions]. J Dtsch Dermatol Ges 2004;2:1013-1023.
references.citation: Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-693.
references.citation: Lerch M, Bircher AJ. Systemically induced allergic exanthema from mercury. Contact Dermatitis 2004;50:349-353.